Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk

Objective: The identification of a vitamin D–responsive (VDRE) motif within the HLA-DRB1*15:01 promoter region provides an attractive explanation for the combined effects of HLA-DR inheritance and vitamin D exposure on multiple sclerosis (MS) risk. We therefore sought to incorporate HLA-DRB1 promoter variation, including the VDRE motif, in an assessment of HLA-DRB1–associated MS risk. Methods: We utilized 32 homozygous HLA cell lines (covering 17 DRB1 alleles) and 53 heterozygote MS samples (20 DRB1 alleles) for HLA-DRB1 promoter sequencing. The influence of HLA-DRB1 variation on MS risk was then assessed among 466 MS cases and 498 controls. Results: The majority of HLA*DRB1 alleles (including HLA-DRB1*15:01) express the functional VDRE motif, apart from HLA-DRB1*04, *07, and *09 alleles that comprise the HLA-DR53 serologic group. Allele-specific variation within functional X-box and Y-box motifs was also associated with serologically defined HLA-DR haplotypes. Incorporating these results in an analysis of MS risk, we identified a strong protective effect of HLA-DRB1*04, *07, and *09 (DR53) alleles (p = 10−12) and elevated risk associated with DRB1*15 and *16 (DR51) and *08 (DR8) alleles (p < 10−18). Conclusions: HLA-DRB1 groups corresponding to serologic HLA-DR profiles as well as promoter polymorphism haplotypes effectively stratified MS risk over an 11-fold range, suggesting functional relationships between risk-modifying HLA-DRB1 alleles. An independent contribution of VDRE motif variation to increase MS risk was not discernible, although vitamin D–dependent regulation of HLA-DR expression may still play an important role given that HLA-DRB1*04/*07/*09 (DR53) alleles that express the “nonresponsive” VDRE motif were associated with significantly reduced risk of MS.

[1]  J. Damoiseaux,et al.  Effects of vitamin D on the peripheral adaptive immune system: a review. , 2011, Autoimmunity reviews.

[2]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[3]  G. Ebers,et al.  Relationship of UV exposure to prevalence of multiple sclerosis in England , 2011, Neurology.

[4]  Bjoern Peters,et al.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.

[5]  L. Wald,et al.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France , 2011, Neurology.

[6]  J. Mcleod,et al.  Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration , 2011, Journal of Neurology.

[7]  Gavin Giovannoni,et al.  A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. , 2010, Genome research.

[8]  C. Mathieu,et al.  Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  A. Ponsonby,et al.  Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis , 2010, BMJ : British Medical Journal.

[10]  Jake K. Byrnes,et al.  HLA-DRB1 and month of birth in multiple sclerosis , 2009, Neurology.

[11]  R. Goswami,et al.  Interaction of Vitamin D Receptor with HLA DRB1*0301 in Type 1 Diabetes Patients from North India , 2009, PloS one.

[12]  J. Knight,et al.  Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.

[13]  A. Sadovnick,et al.  Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. , 2008, Human molecular genetics.

[14]  S. Spellman,et al.  National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  D. Williamson,et al.  HLA-DR15 haplotype and multiple sclerosis: a HuGE review. , 2007, American journal of epidemiology.

[16]  N. Setterblad,et al.  Evolutionary relationship between human major histocompatibility complexHLA-DR haplotypes , 1996, Immunogenetics.

[17]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[18]  A. Sadovnick,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[19]  D. Singal,et al.  Polymorphism in the Y box controls level of cytokine-mediated expression of HLA-DRB1 genes. , 2001, Tissue antigens.

[20]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[21]  T. Lehtimäki,et al.  The combination of HLA-DR1 and HLA-DR53 protects against MS , 2001, Neurology.

[22]  F. Christiansen,et al.  HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. , 2001, Tissue antigens.

[23]  M. Nei,et al.  Locus specificity of polymorphic alleles and evolution by a birth-and-death process in mammalian MHC genes. , 1999, Molecular biology and evolution.

[24]  H. Rammensee,et al.  Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. , 1994, Journal of immunology.

[25]  P. Emery,et al.  The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence. , 1993, Human immunology.

[26]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[27]  C. Davenport.  MULTIPLE SCLEROSIS: FROM THE STANDPCINT OF GEOGRAPHIC DISTRIBUTION AND RACE , 1922 .